menu

How Long Is too Long? Evolving Literature on Long-term Anticoagulation Therapy After VTE

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

How Long Is too Long? Evolving Literature on Long-term Anticoagulation Therapy After VTE

0.50 credits
25 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.50 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Although evidence corroborates the safety and efficacy of managing low-risk patients with VTE in outpatient settings through prophylactic extension, the majority of this subtype is still being treated in hospital settings. 

  • Disclosure of Conflicts of Interest

    American College of Chest Physicians® (CHEST) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any relevant financial relationships that create a conflict of interest. It is not the intent of American College of Chest Physicians® (CHEST) to disqualify anyone from participating in this educational activity, but to resolve any conflicts of interest that may arise from financial relationships with commercial interests. All conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, and/or the Professional Standards Committee to ensure that such situations are properly evaluated and, if necessary, resolved. American College of Chest Physicians® (CHEST) educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American College of Chest Physicians® (CHEST) CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relevant financial relationships will be made available on-site during all educational activities.

    The following faculty members of this activity have disclosed to American College of Chest Physicians® (CHEST) that they have a relevant financial relationship with a commercial interest as it relates to the activity:

    Speaker - Marc Carrier MD, FRCPC
    Professor of Medicine
    Department of Medicine, Division of Hematology
    Senior Scientist, Ottawa Hospital Research Institute
    University of Ottawa,
    Ottawa, ON 

    Financial disclosure: Grant/Research Support: Leo Pharma, Inc., BMS, Pfizer; Consultant: Leo Pharma, Inc., Pfizer, Bayer, Servier Pharmaceuticals LLC

    Speaker - Rachel P.  Rosovsky, MD, MPH
    Director, Thrombosis Research, Division of Hematology
    Massachusetts General Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, MA
    Vice President, Pulmonary Embolism Response Team Consortium

    Financial disclosure: Consultant - Dova Pharmaceuticals Inc., Inari Medical, Janssen Pharmaceuticals; Grant/Research - Janssen Pharmaceuticals, BMS; Advisory Committee Member - BMS

    The following faculty members of this activity have indicated to American College of Chest Physicians® (CHEST) that they have no relevant financial relationships with any commercial interests:

    Moderator - Lisa Baumann Kreuziger, MD, MS
    Investigator, Blood Research Institute, Versiti
    Associate Professor, Hematology & Oncology
    Medical College of Wisconsin
    Medical Director, Antithrombotic Therapy Management Program
    Froedtert Health
    Milwaukee, WI 

    Financial disclosure: Nothing to disclose.

    Chair -Shari Barnett Brosnahan, MD
    Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine
    Associate Program Director, Pulmonary and Critical Care Fellowship
    Investigator, NYU Langone Translational Lung Biology Laboratory
    New York University Langone Health System
    New York City, NY 

    Financial disclosure: Nothing to disclose.

    Chair - Parth Rali, MD
    Associate Professor
    Division of Thoracic Medicine and Surgery
    Director, TUHS PERT Program
    Lewis Katz School of Medicine
    Temple University Hospital, PA

    Financial disclosure: Nothing to disclose.

  • Target Audience

    Pulmonary vascular disease, cardiovascular medicine and surgery, pulmonary specialist, critical care, primary care providers, internists, and emergency medicine physicians.

  • Learning Objectives

    Review the current controversies related to VTE prophylactic extension and risk/benefits to inform shared decision-making. 

  • Accreditation and Credit Designation Statements

    Physician Credit
    The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

    The American College of Chest Physicians designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing Credit
    Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 0.50 contact hour. 

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

    Physician Assistants
    American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.50 Category 1 credits for completing this activity. 

    Maintenance of Certification Statement
    Successful completion of this CME activity enables the participant to earn up to 0.50 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

    Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 businessdays after claiming for points to be reflected on your ABIM record.

  • Disclaimer

    The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives, and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

    Copyright © 2021 by the American College of Chest Physicians.

    Copyright not claimed on material authorized by the US Government.
    All rights reserved. No part of this publication may be reproduced in any manner without permission of the publisher.

    American College of Chest Physicians
    2595 Patriot Boulevard
    Glenview, IL 60026
    Telephone: +1 (224) 521-9800; Fax: +1 (224) 521-9801
    chestnet.org

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    Supported by an educational grant from Janssen Pharmaceuticals, Inc., Administered by Janssen Scientific Affairs, LLC

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Although evidence corroborates the safety and efficacy of managing low-risk patients with VTE in outpatient settings through prophylactic extension, the majority of this subtype is still being treated in hospital settings. 

  • Disclosure of Conflicts of Interest

    American College of Chest Physicians® (CHEST) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any relevant financial relationships that create a conflict of interest. It is not the intent of American College of Chest Physicians® (CHEST) to disqualify anyone from participating in this educational activity, but to resolve any conflicts of interest that may arise from financial relationships with commercial interests. All conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, and/or the Professional Standards Committee to ensure that such situations are properly evaluated and, if necessary, resolved. American College of Chest Physicians® (CHEST) educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American College of Chest Physicians® (CHEST) CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relevant financial relationships will be made available on-site during all educational activities.

    The following faculty members of this activity have disclosed to American College of Chest Physicians® (CHEST) that they have a relevant financial relationship with a commercial interest as it relates to the activity:

    Speaker - Marc Carrier MD, FRCPC
    Professor of Medicine
    Department of Medicine, Division of Hematology
    Senior Scientist, Ottawa Hospital Research Institute
    University of Ottawa,
    Ottawa, ON 

    Financial disclosure: Grant/Research Support: Leo Pharma, Inc., BMS, Pfizer; Consultant: Leo Pharma, Inc., Pfizer, Bayer, Servier Pharmaceuticals LLC

    Speaker - Rachel P.  Rosovsky, MD, MPH
    Director, Thrombosis Research, Division of Hematology
    Massachusetts General Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, MA
    Vice President, Pulmonary Embolism Response Team Consortium

    Financial disclosure: Consultant - Dova Pharmaceuticals Inc., Inari Medical, Janssen Pharmaceuticals; Grant/Research - Janssen Pharmaceuticals, BMS; Advisory Committee Member - BMS

    The following faculty members of this activity have indicated to American College of Chest Physicians® (CHEST) that they have no relevant financial relationships with any commercial interests:

    Moderator - Lisa Baumann Kreuziger, MD, MS
    Investigator, Blood Research Institute, Versiti
    Associate Professor, Hematology & Oncology
    Medical College of Wisconsin
    Medical Director, Antithrombotic Therapy Management Program
    Froedtert Health
    Milwaukee, WI 

    Financial disclosure: Nothing to disclose.

    Chair -Shari Barnett Brosnahan, MD
    Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine
    Associate Program Director, Pulmonary and Critical Care Fellowship
    Investigator, NYU Langone Translational Lung Biology Laboratory
    New York University Langone Health System
    New York City, NY 

    Financial disclosure: Nothing to disclose.

    Chair - Parth Rali, MD
    Associate Professor
    Division of Thoracic Medicine and Surgery
    Director, TUHS PERT Program
    Lewis Katz School of Medicine
    Temple University Hospital, PA

    Financial disclosure: Nothing to disclose.

  • Target Audience

    Pulmonary vascular disease, cardiovascular medicine and surgery, pulmonary specialist, critical care, primary care providers, internists, and emergency medicine physicians.

  • Learning Objectives

    Review the current controversies related to VTE prophylactic extension and risk/benefits to inform shared decision-making. 

  • Accreditation and Credit Designation Statements

    Physician Credit
    The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

    The American College of Chest Physicians designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing Credit
    Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 0.50 contact hour. 

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

    Physician Assistants
    American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.50 Category 1 credits for completing this activity. 

    Maintenance of Certification Statement
    Successful completion of this CME activity enables the participant to earn up to 0.50 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

    Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 businessdays after claiming for points to be reflected on your ABIM record.

  • Disclaimer

    The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives, and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

    Copyright © 2021 by the American College of Chest Physicians.

    Copyright not claimed on material authorized by the US Government.
    All rights reserved. No part of this publication may be reproduced in any manner without permission of the publisher.

    American College of Chest Physicians
    2595 Patriot Boulevard
    Glenview, IL 60026
    Telephone: +1 (224) 521-9800; Fax: +1 (224) 521-9801
    chestnet.org

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    Supported by an educational grant from Janssen Pharmaceuticals, Inc., Administered by Janssen Scientific Affairs, LLC

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule18 Jan 2022
Webpack App